MANUSO JAMES S J 4

What Happened

• James S. Manuso, a director of Opus Genetics, was granted 24,367 restricted stock units (RSUs) on April 20, 2026. The grant shows an acquisition amount of 24,367 shares at $0.00 (transaction code A — award/grant). This is a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-20; Filing date: 2026-04-22 (filed timely).
• Awarded shares: 24,367 RSUs; reported grant price: $0.00 (typical for RSU grants).
• Shares owned after transaction: Not specified in the Form 4.
• Footnote: The RSUs vest on the earlier of one year after the grant or the day before the issuer’s next annual stockholder meeting, subject to the reporting person’s continued service through the vesting date (see footnote F1).
• Transaction code: A = Award/Grant.

Context

• RSU grants are a common form of director compensation and do not represent an immediate cash purchase or sale. Value to the holder will depend on Opus Genetics’ share price at vesting and any applicable tax or withholding events when RSUs vest and convert to shares.
• Such awards indicate compensation alignment with shareholders but should not be interpreted alone as a buy/sell signal.